Also worth noting GTG have employed a VP of Business Development in the US..! Great news moving forward imo.
From the report: "To support the launch of geneType and to drive the tests’ adoption we have undertaken a number of strategic initiatives.
In the US we have initiated a number of key strategies, with the appointment of an experienced VP of Business Development,John Haslet. John has considerable experience in building sales networks for the geneType brand in three key sales channels,namely:
• Independent Doctor Networks (IDNs) • Concierge Medicine • Payer Systems"
Very nice.
.
GTG Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
